For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
G protein-coupled receptors (GPCRs) which are also known as seven-transmembrane domain receptors, 7TM receptors, heptahelical receptors, serpentine receptor, and G protein-linked receptors (GPLR), constitute a large protein family of receptors that detect molecules outside the cell and activate internal signal transduction pathways and, ultimately, cellular responses. Coupling with G proteins, they are called seven-transmembrane receptors because they pass through the cell membrane seven times.
LPI (LP Information)' newest research report, the "G-Protein Coupled Receptor (GPCR) Targeting Industry Forecast" looks at past sales and reviews total world G-Protein Coupled Receptor (GPCR) Targeting sales in 2022, providing a comprehensive analysis by region and market sector of projected G-Protein Coupled Receptor (GPCR) Targeting sales for 2023 through 2029. With G-Protein Coupled Receptor (GPCR) Targeting sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world G-Protein Coupled Receptor (GPCR) Targeting industry.
This Insight Report provides a comprehensive analysis of the global G-Protein Coupled Receptor (GPCR) Targeting landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on G-Protein Coupled Receptor (GPCR) Targeting portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global G-Protein Coupled Receptor (GPCR) Targeting market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for G-Protein Coupled Receptor (GPCR) Targeting and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global G-Protein Coupled Receptor (GPCR) Targeting.
The global G-Protein Coupled Receptor (GPCR) Targeting market size is projected to grow from US$ 86 million in 2022 to US$ 103.7 million in 2029; it is expected to grow at a CAGR of 103.7 from 2023 to 2029.
Global G-Protein Coupled Receptor (GPCR) Targeting key players include Thermo Fisher Scientific, PerkinElmer, Merck, BD Biosciences, Molecular Devices etc. Global top five manufacturers hold a share over 40%.
North America is the largest market, with a share over 40%, followed by Japan and Europe, both have a share over 35% percent.
In terms of product, GPCR Consumables is the largest segment, with a share over 60%. And in terms of application, the largest application is Oncology followed by Cardiovascular System.
This report presents a comprehensive overview, market shares, and growth opportunities of G-Protein Coupled Receptor (GPCR) Targeting market by product type, application, key manufacturers and key regions and countries.
Segmentation by type
- GPCR Consumables
- GPCR Equipment
Segmentation by application
- Cardiovascular System
- Central Nervous System
This report also splits the market by region:
- - United States
- - Canada
- - Mexico
- - Brazil
- - China
- - Japan
- - Korea
- - Southeast Asia
- - India
- - Australia
- - Germany
- - France
- - UK
- - Italy
- - Russia
- Middle East & Africa
- - Egypt
- - South Africa
- - Israel
- - Turkey
- - GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
- Thermo Fisher Scientific
- BD Biosciences
- Molecular Devices
- Enzo Life Sciences
Key Questions Addressed in this Report
What is the 10-year outlook for the global G-Protein Coupled Receptor (GPCR) Targeting market?
What factors are driving G-Protein Coupled Receptor (GPCR) Targeting market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do G-Protein Coupled Receptor (GPCR) Targeting market opportunities vary by end market size?
How does G-Protein Coupled Receptor (GPCR) Targeting break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?